Fisher & Paykel Healthcare Corporation Limited Stock price Australian S.E.

Equities

FPH

NZFAPE0001S2

Medical Equipment, Supplies & Distribution

Market Closed - Australian S.E. 01:10:10 2024-03-28 am EDT 5-day change 1st Jan Change
23.66 AUD -2.75% Intraday chart for Fisher & Paykel Healthcare Corporation Limited +5.39% +8.38%

Financials

Sales 2024 * 1.73B 1.03B 1.59B Sales 2025 * 1.94B 1.16B 1.78B Capitalization 14.98B 8.94B 13.73B
Net income 2024 * 259M 155M 237M Net income 2025 * 331M 198M 303M EV / Sales 2024 * 8.74 x
Net Debt 2024 * 171M 102M 157M Net Debt 2025 * 242M 144M 222M EV / Sales 2025 * 7.85 x
P/E ratio 2024 *
57.5 x
P/E ratio 2025 *
44.8 x
Employees 6,420
Yield 2024 *
1.53%
Yield 2025 *
1.67%
Free-Float 91.12%
More Fundamentals * Assessed data
Dynamic Chart

Latest transcript on Fisher & Paykel Healthcare Corporation Limited

1 day-2.75%
1 week+5.39%
Current month+2.91%
1 month+0.94%
3 months+7.35%
6 months+19.92%
Current year+8.38%
More quotes
1 week
23.19
Extreme 23.19
24.77
1 month
21.88
Extreme 21.88
24.77
Current year
21.36
Extreme 21.36
24.77
1 year
18.58
Extreme 18.58
26.08
3 years
16.11
Extreme 16.11
34.29
5 years
14.00
Extreme 14
34.92
10 years
3.62
Extreme 3.62
34.92
More quotes
Managers TitleAgeSince
Chief Executive Officer 63 84-12-31
Director of Finance/CFO - 19-02-28
Chief Tech/Sci/R&D Officer - 06-12-31
Members of the board TitleAgeSince
Director/Board Member 66 90-04-30
Chairman - 15-09-30
Chief Executive Officer 63 84-12-31
More insiders
Date Price Change Volume
24-03-28 23.66 -2.75% 871,671
24-03-27 24.33 -0.12% 282,057
24-03-26 24.36 +1.29% 541,693
24-03-25 24.05 -0.54% 498,976
24-03-22 24.18 +7.71% 757,964

Delayed Quote Australian S.E., March 28, 2024 at 01:10 am EDT

More quotes
Fisher & Paykel Healthcare Corporation Limited designs, manufactures and markets products and systems for use in acute and chronic respiratory care, surgery and the treatment of obstructive sleep apnea. The Company provides medical device products and systems for use in both hospital and homecare settings. Its hospital product group includes products used in invasive ventilation, noninvasive ventilation, nasal high flow therapy, anesthesia, and laparoscopic and open surgery. Its homecare product group includes devices and systems used to treat obstructive sleep apnea (OSA) and provide respiratory support in the home, which include its continuous positive airway pressure (CPAP) therapy masks as well as flow generators, interfaces, and data management technologies. The Company’s products are sold in over 120 countries worldwide. It operates across Canada, the United States of America, Mexico, Costa Rica, the United Kingdom, Switzerland, India and others.
Related indices
More about the company
Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
14
Last Close Price
25.65 NZD
Average target price
23.91 NZD
Spread / Average Target
-6.78%
Consensus
  1. Stock
  2. Equities
  3. Stock Fisher & Paykel Healthcare Corporation Limited
  4. Stock Fisher & Paykel Healthcare Corporation Limited - Australian S.E.